Device Transactions Device companies finished off 2012 raising $1.1 billion in the fourth quarter (a 40% increase over Q3’s $801 million), capping off the year with a grand total of $4 billion in fund
IN VITRO DIAGNOSTICS Mergers & Acquisitions Amarantus Bioscience Inc. Power3 Medical Products Inc. Amarantus BioScience Holdings Inc. (biologics and tests for CNS and cardiovascular diseases) is a